BioProcess International Magazine - HomeBioProcess International | Covering the whole development process for the global biotechnology industry

Read Now

Watch Now

Read Now

Download Now

Featured Content

Moderna: How to make 1 billion doses of a COVID-19 vaccine

The right levels of capacity, equipment, staff, and raw materials are key in scaling up COVID-19 vaccine manufacturing says Moderna.

Read Now

The Role of New Technology in Enabling Cell and Gene Therapies

New techniques for viral (AAV, LV, and baculovirus) vector production are improving and streamlining cell and gene therapy manufacture.

Read Now

Early Stage Analytical Considerations for Late Stage Biologics Success

Sponsored Sound analytical method development applied early in a drug product's life cycle can reduce lead times and costs while maintaining quality standards.

Read Now

Biosimilars Pipeline and Market Trends

Drug patent concerns and healthcare-system recalcitrance continue to prevent the United States from developing robust biosimilars markets.

Read Now

Managing Risk in Single-Use Systems Design and Implementation: A Shared Responsibility

Sponsored Clearly defined processes built with QbD principles help to ensure that single-use systems will be fit for purpose and supply requisite performance data.

Read Now

The Evolving Role of the Outsourcing Manufacturer: Why CDMO Is the New Normal

Sponsored Contract manufacturers increasingly are offering biologics development services, approaching the goal of "end to end" biologics production.

Read Now

Fighting Alzheimer’s Disease with a Breakthrough Peptide

Canadian biopharmaceutical company NervGen is producing a peptide-based therapy that could be a breakthrough treatment for Alzheimer's disease.

Read Now

BVDV Risk Mitigation: Dealing with Bovine Viral Diarrhea Virus in Serum

Collection, manufacturing, and treatment processes must be rigorous to minimize the risk of bovine viral diarrhea virus appearing in serum products.

Read Now